Men run a higher risk for cardiovascular disease than women, even if hypertensive. This has been attributed to a more pronounced central (abdominal) fat distribution in men as well as menopausal state in women. The hypothesis to be tested in hypertensives was that men have more pronounced insulin resistance and other cardiovascular risk factors than pre-menopausal, but not post-menopausal, women. We carried out a cross-sectional observation study of middle-aged hypertensives of both sexes, divided into two age groups, below or over 50 years of age. The study was performed in untreated out-patients, visiting a hypertension policlinic, in Uppsala, Sweden. Three hundred men and 170 women with a mean age of 57 years were investigated. Measurements were taken by: physical examination (body mass index, waist-to-hip ratio, blood pressure); intravenous glucose tolerance test (IVGTT);
Introduction
It is well established that sex differences exist in the risk for cardiovascular disease, especially for myocardial infarction. 1 In hypertensive patients this sex difference in the incidence of coronary heart disease and stroke is still present. 2, 3 This overall sex difference may be due to either age-related biological or socio-cultural gender differences, eg, in lifestyle or in working conditions. 4 Earlier studies, focusing on biological differences, have shown a male predominance in various risk factors linked to insulin, sex hormones, 5, 6 and to abdominal obesity. 7 Thus, normal males have higher blood pressure in their middle ages, 8, 9 more pronounced lipid alterations, 10 and, as shown in younger subjects, a lower level of insulin sensitivity per kilogram of lean body mass, 11 than matched female subjects. There is also a higher prevalence 12 and incidence 13 of type 2 diabetes in middle-aged men than in women, which is reversed after the age of 60. In post-menopausal women, however, lipid levels tend to increase and may exceed Correspondence: Dr Hans Lithell, Department of Geriatrics, P.O. Box 609, S-750 02 Uppsala, Sweden Received 18 December 1998; revised and accepted 24 August 1999 euglycaemic hyperinsulinaemic clamp; and blood sampling for lipoprotein lipid fractions, uric acid, and free fatty acids. The results were that pre-menopausal women showed a higher insulin-mediated glucose disposal (7.6 vs 5.8 mg/kg/min; P Ͻ 0.01), and lower fasting glucose (4.9 vs 5.2 mmol/l; P Ͻ 0.05) than men, as well as a more advantageous lipoprotein profile. However, in post menopausal women insulin sensitivity decreased and the lipoprotein profile deteriorated. Women still showed higher levels of high-density lipoprotein (HDL)-cholesterol, and men a higher waist-to-hip ratio and levels of uric acid, in both age groups. It was concluded that post-menopausal hypertensive women are relatively more insulin resistant than pre-menopausal ones in comparison with men in the same age group and with the same degree of overall obesity. Journal of Human Hypertension (2000) 14, 51-56 corresponding levels in men.
14 Furthermore, post menopausal state is of great importance for the overall cardiovascular risk in women. The earlier the menopause, the higher the age-adjusted cardiovascular mortality rate, presumably due to a lack of oestrogen protection in the post-menopausal female. 15 Central obesity is a major contributing factor for observed sex differences in risk factors. 16, 17 Since the discovery that the abdominal fat distribution is related to the occurrence of coronary heart disease in both men 18 and women, 19 much research has focused on the distribution of fat tissue as a determinator of metabolic disturbances. Recently it was shown that sex differences in risk factors were almost entirely explained by differences in visceral adipose tissue accumulation, but a higher level of high-density lipoprotein (HDL)-cholesterol in obese, pre-menopausal women than in men was not fully explained by this factor. 20 Sex differences in lipid levels, including HDL cholesterol, were also recently shown in hypertensive men and women, even though insulin sensitivity and the fat distribution were not determined. 21 Therefore, the aim of the present study was to clarify sex differences in cardiovascular risk factors in a group of hypertensive subjects, eg in fat distri-
Subjects and methods

Subjects
Three hundred male hypertensives and 170 female hypertensives were recruited, including 143 newly detected hypertensives from a previous study based on a health survey in Uppsala, Sweden. 22 All subjects were divided into two age groups, below or above 50 years of age, as an estimate of menopausal age in Sweden (median 50-51 years). Thus 77 men and 28 women belonged to the younger age group (р50 years), and 223 men and 142 women to the older age group (Ͼ50 years). Patients with known diabetes mellitus were excluded. All previously treated hypertensives had their medication discontinued at least 4 weeks prior to the investigations, to avoid carry-over effects of drugs on the metabolism. 23 Habitual smoking was recorded in 22% of men and 17% of women. Patients were investigated in a random order throughout the year to avoid seasonal variation in biological variables.
Physical examination
This included the measurement of weight (kg), height (m), and supine blood pressure (mm Hg) after a 10-min rest (in the right arm; mean of three readings; Korotkoff phase V). A large blood pressure cuff was used when appropriate. Body mass index, as a measure of overall obesity, was calculated as BMI (kg/m 2 ). Lean body mass was not measured. The waist-to-hip ratio, as a measure of abdominal obesity, was defined as the circumference (cm) at the umbilical level divided by the circumference (cm) measured over the widest part of the gluteal region.
Metabolic investigations
The insulin response to an intravenous glucose tolerance test (IVGTT) and insulin sensitivity according to an euglycaemic hyperinsulinaemic clamp were evaluated on two separate days. Each participant was instructed to adhere to a diet rich in carbohydrates and to refrain from extreme physical exercise or inactivity for at least 5 days before the investigations. Patients were invited in the morning after an overnight fast for 10-12 h, also including abstinence from smoking.
Intravenous glucose tolerance test
An IVGTT was performed as previously described in detail, 22, 24 with injection of 300 mg/kg body weight (bw) of glucose. Blood glucose was measured by the glucose oxidase method (Opotimate™, AmesGilford, Elkhart, IN, USA). The disappearance rate of glucose was expressed as a k value calculated from the formula k = 100 e log 2/ t 1/2 ; t 1/2 being the time (min) required to half the glucose concentration. Immunoreactive insulin was assayed in plasma, using a commercial radio immunoassay kit (Phadeseph® Insulin RIA, Pharmacia, Uppsala, Sweden). The peak insulin response was defined as the mean of the values obtained at 4, 6 and 8 min, and the insulin increment as the difference between the peak insulin and the fasting plasma insulin concentration. Mean fasting insulin was calculated from samples taken on 2 separate days. HbA 1c was measured by fast performance liquid chromatography (normal range, 3.5-6.0%).
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Insulin sensitivity studies
The euglycaemic insulin clamp technique was used as has previously been described in detail. 22, 26 The insulin (Actrapid® Human, Novo, Copenhagen, Denmark) infusion rate during the clamp study was 56 mU/m 2 per min in all subjects, resulting in a mean plasma insulin concentration of 92 mU/l (range 68-134 mU/l). Steady-state plasma glucose and insulin concentrations were calculated as the mean of all values obtained between the 20th and the 120th min of the clamp procedure.
The target level of plasma glucose was 5.1 mmol/l. The coefficient of variation for the steady-state plasma glucose concentration was on the average 3.4%. The total amount of glucose infused serves as a measure of the subject's sensitivity to the prevailing plasma insulin concentrations. The insulinmediated glucose disposal (M) during the glucose clamp was calculated on the basis of the amount of glucose infused and is expressed per kg body weight (M; mg × kg bw
. The mean glucose uptake rate for the last 60 min of the clamp was used as the main variable for an individual assessment. M was finally divided with the mean insulin value during the last 60 min of the clamp to form the insulin sensitivity index (M/I).
Lipids
Lipoproteins in serum were analysed by means of an ultracentrifugation step and a precipitation technique (phosphotungstate/MgCl 2 ), as described by Seigler and Wu. 27 Triglycerides and cholesterol were measured by enzymatic techniques (Boehringer Mannheim, Mannheim, Germany) in a Multistat III/LS (Instrumentation Laboratories, Lexington, MA, USA) or Monarch centrifugal analyser. Serum free fatty acids (FFA) were determined by an enzymatic colorimetric method, using a commercial kit (Wako Chemicals GmbH, Neuss, Germany) applied for analyses in the centrifugal analyser.
Other variables
Serum uric acid was analysed by routine laboratory methods at the Department of Clinical Chemistry of the University Hospital, Uppsala.
No data on lifestyle (diet, exercise) were recorded with the exception of smoking habits.
Statistics
All values are given as means and standard deviations (s.d.). An unpaired Student's t-test was used 
Results
Mean values (s.d.) for all variables in the hypertensive men and women are given in Tables 1 and 2 . In the younger age group (р50 years) men showed a higher waist-to-hip ratio and lower insulin sensitivity as well as k-value than women in spite of the fact that women were slightly older than the men (44.8 vs 42.2 years) ( Table 1) . Very low-density lipoprotein (VLDL) cholesterol, but not HDL cholesterol, as well as triglycerides (total, VLDL) and uric acid were higher in the male group than in the female group (Table 2) .
In the older age group (Ͼ50 years), the sex difference in insulin sensitivity disappeared, but men 
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showed a higher waist-to-hip ratio, diastolic blood pressure, fasting glucose levels, and insulin peak at IVGTT than women (Table 1) . These post-menopausal women had higher cholesterol (total, LDL, HDL) and free fatty acids than the men, but lower uric acid levels ( Table 2) . Sub-fractions of triglycerides (Tg) differed in the way that men had higher VLDL-Tg, but lower LDL-Tg and HDL-Tg, than women in this age group. The waist-to-hip ratio correlated with age in all women (r = 0.30, P Ͻ 0.001), but not in men (r = 0.08). In the total group, highly significant correlations (P Ͻ 0.001) were seen between waist-to-hip ratio and BMI (women: r = 0.54, men: r = 0.61), as well as between waist-to-hip ratio and insulinmediated glucose disposal, M (women: r = −0.50, men: r = −0.52).
Discussion
The main findings of the present study in untreated hypertensive subjects were the sex differences seen
Journal of Human Hypertension in several cardiovascular risk factors, most pronounced in the younger age group (р50 years) that included pre-menopausal women. In this age group a sex difference was noticed in that men had a higher fasting glucose as well as triglyceride levels, but a lower insulin sensitivity index (M/I) than women (6.7 vs 8.4 mg/kg/min/I; P Ͻ 0.05). The waist-to-hip ratio, being a marker of abdominal obesity, is a well-known predictor of these metabolic disturbances. This ratio was higher in men than in women irrespective of age group. In postmenopausal hypertensive women, however, lipid levels deteriorated with an increase in total cholesterol, but a decrease in HDL cholesterol levels. Sex difference in the insulin sensitivity index was no longer observed in the older age group, partly due to the female weight increase from a BMI of 26.3 kg/m 2 in younger women to 28.2 kg/m 2 in the older women. This implies that the relative advantage of women over men in risk factors is lost in post-menopause when the overall cardiovascular risk in women increases. However, this does not seem to involve heart rate, a factor that decreases with age in these female hypertensives. An elevated heart rate is otherwise regarded as a cardiovascular risk factor in most epidemiological studies, most notably in a follow-up study of hypertensive patients of both sexes in the Framingham Study. 28 It should also be pointed out that the number of young women in this study was low so that this group represents only 6% of the total cohort, making the results/conclusions in this group less weighty.
Yki-Järvinen 11 has previously shown a lower insulin sensitivity (M) and decreased glucose uptake per kg of lean body mass in young, healthy men compared to matched women, but this finding was later disputed by other investigators. 29, 30 However, both previous clamp studies showed the same tendency for lower uncorrected M-values in men compared to women (8.3 vs 8.8 mg/kg/min), 11 and (6.3 vs 7.1 mg/kg/min), 30 that we have found. Hypertensive females tend to resemble males in their type of fat distribution and glucose metabolism, as compared with healthy normotensive females. Males in our study, however, still had a higher waist-to-hip ratio and a lower k value than females, but the latter finding was only seen in the younger age group. Long-term glucose tolerance was similar in both sexes as determined by HbA 1c levels. This might be influenced by equal mean levels of BMI in the study groups. On the contrary, healthy normotensive males are taller and heavier and have a higher BMI than females, at least in their middle age. 31 In obese women the abdominal fat distribution is, however, more important than overall obesity for the prediction of insulin resistance. 32 Men showed higher fasting glucose than females in both age groups, indicating a higher hepatic glucose production in the fasting state. This may be due to a sex difference in insulin resistance on the hepatic level, not measured in this study.
Our findings of sex differences in hypertensives from the younger age group were similar to those of a Norwegian study in 41-year-old subjects. 21 Higher levels of heart rate and HDL cholesterol levels, but lower triglyceride levels, in women compared to men were noted in both studies with the corresponding age groups. Indices of insulin secretion and action, as well as the waist-to-hip ratio, were, however, not measured in the Norwegian study which is why no comparisons can be made for these variables. In another study from the same group it has been shown that insulin sensitivity and the waist-to-hip ratio do not differ between hypertensive or normotensive pre-menopausal females, 33 indicating the protective role of endogenous sex hormones.
Which are the plausible background factors for our findings of sex differences related to age and menopausal state? Muscle fibre composition is linked to obesity, 34, 35 hypertension, 36 insulin resistance, 37 and type 2 diabetes. 38 Normal females have a different muscle composition than males, favouring the relative predominance of type-1 (oxidative) muscle fibres. This may represent an explanation for the suggested higher degree of insulin sensitivity in healthy young women than in men, as expressed per kilogram of lean body mass.
11 Differences in insulin sensitivity may also relate to the balance of sex hormones, as muscle fibre composition is influenced by androgens. Indeed, metabolic disturbances linked to the insulin resistance of aging 39 may be improved by hormonal replacement therapy, in both men 40 and women, 41 if a relative sex-specific hormonal deficiency exists. Whether muscle fibre composition and sex hormone levels undergo changes in postmenopausal hypertensive females compared with matched normotensive females is not known, but hypertensive males of a corresponding age have a relative decrease in both total and free testosterone levels compared with normotensive males. 42 Muscle fibre composition tends to change in a more unfavourable way in the diabetic state in both sexes, and more so in females with a high than with a low waist-to-hip ratio. 38 Finally, there may exist sexspecific associations between insulin sensitivity, visceral fat accumulation and metabolic disturbances that are also age-related, 43 as illustrated by findings in pre-and post-menopausal females. 44 One important factor in this respect, explaining sex differences in lipids, is a high femoral adipose tissue lipoprotein lipase activity that in pre-menopausal healthy females correlates with a more favourable lipoprotein profile. 45 If the influence of abdominal fat distribution is statistically abolished, there does not any longer exist a sex difference in cardiovascular morbidity and mortality. 46 In conclusion, pre-menopausal hypertensive females are not as insulin resistant as corresponding males and also have lower levels of fasting glucose. This advantage is lost in post-menopause when the cardiovascular risk increases in spite of a male predominance in increased waist-to-hip ratio, irrespective of age.
